Borkowetz, Angelika http://orcid.org/0000-0001-7257-0238
Sommer, Ulrich
Baretton, Gustavo
Gruellich, Carsten
Bürk, Björn Thorben
Erb, Holger H. H.
Thomas, Christian
,
Funding for this research was provided by:
Ipsen Biopharmaceuticals
Technische Universität Dresden
Article History
Received: 6 August 2023
Accepted: 11 January 2024
First Online: 22 February 2024
Declarations
:
: AB declares Research funding: IPSEN; Consulting fees: Pfizer, Steba Biotech, AstraZeneca, Merck, BK Medicals, Wolf; Travel expenses: Astellas, Janssen, IPSEN, Intuitive Surgical; Payment or honoraria for lectures, presentations: Janssen, Astellas, IPSEN, Steba Biotech, Bayer, Pfizer, Merck; Involvement in clinical trials: MSD, Roche; Stock or stock options: none. HE declares Research funding: Astellas Pharma Inc.; Payment or honoraria for presentations: Astellas Pharma Inc., Novartis; Stock or stock options: none. All other authors do not claim any conflict of interest.
: All procedures performed in studies involving human participants followed the institutional research committee’s ethical standards and the 1964 Helsinki Declaration and its later amendments or comparable standards. Ethical approval was obtained by the Ethical Committee of the University of Heidelberg (Study no. S-539/20139). This study does not contain any studies with animals.
: All patients provided written informed consent.